Siegfried and ROI: Swiss firm sees revs soar and says new API biz will drive growth
The Siegfried Group has reported record sales for fiscal 2015 and predicted the API business it bought from BASF will drive further growth this year.
The Siegfried Group has reported record sales for fiscal 2015 and predicted the API business it bought from BASF will drive further growth this year.
The partnership with recombinant protein development firm GTP Technologies will create an end-to-end manufacturing service, speeding up production of monoclonal antibodies and reducing costs, says Novasep.
Sartorius Stedim Biotech (SSB), a supplier for the biopharmaceutical industry, has announced new, ready-to-use assays for testing biosimilars.
The global contract and manufacturing organization (CDMO) announced the construction at a ground breaking ceremony held at its Ravensburg Schuetzenstrasse site.
The funding will be used to accelerate the company’s global expansion of its proprietary digital immunoassay platform into new markets.
Dispatches from DCAT Week 16'
When pharmaceutical companies miss their capacity forecast, it is both costly and time consuming, so many are choosing to outsource in order to mitigate risks.
Drug companies should share more details of their APIs and the green credentials of the companies that supply says an award winning environmental researcher.
Evotec has attributed strong growth in 2015 to its deal with Sanofi and says it will continue to pursue such strategic partnerships.
Hitachi Chemical has licensed cell therapy manufacturing technology from PCT in a deal that may see the firms set up a European JV.